Karyopharm Therapeutics – Stock. Additional stock would be great incentive. | Comparably

Karyopharm Therapeutics – Stock. Additional stock would be great incentive.

Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
This company is accepting feedback from verified employees
EMPLOYEE
PARTICIPANTS
90
TOTAL
RATINGS
2628

Stock. Additional stock would be great incentive.

What are some of the best things about your team?

My team works hard, is dedicated and supportive of one another.

What do you like best about the leadership team?

The team is nimble and willing to take swift action with matters that affect business.

What makes you most happy at work?

It’s fulfilling to pull through initiatives and projects successfully. It’s also nice to feel appreciated or recognition for succe

What is most positive about the culture and environment at your company?

Executive team is supportive and generally willing to take swift action when needed. Innovation and urgency enable a healthy nimble environment.

×
Rate your company